MONTREAL, QUEBEC--(CCNMatthews - April 10, 2007) - MonoGen, Inc. (“Corporation”)(TSX:MOG) today announced that it has entered into an agreement with The Johns Hopkins Hospital (JHH) to evaluate the MonoPrep® liquid-based preparation system for non-gynecological applications during a 6-month trial period. The MonoPrep processor has been installed at JHH under the supervision of the Director of Cytopathology, and the training of laboratory personnel and the processing of research specimens has begun.
